| Product NDC: | 49884-099 | 
| Proprietary Name: | Propafenone Hydrochloride | 
| Non Proprietary Name: | propafenone hydrochloride | 
| Active Ingredient(s): | 225 mg/1 & nbsp; propafenone hydrochloride | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 49884-099 | 
| Labeler Name: | Par Pharmaceutical, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA078540 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20110103 | 
| Package NDC: | 49884-099-01 | 
| Package Description: | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (49884-099-01) | 
| NDC Code | 49884-099-01 | 
| Proprietary Name | Propafenone Hydrochloride | 
| Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (49884-099-01) | 
| Product NDC | 49884-099 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | propafenone hydrochloride | 
| Dosage Form Name | CAPSULE, EXTENDED RELEASE | 
| Route Name | ORAL | 
| Start Marketing Date | 20110103 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Par Pharmaceutical, Inc. | 
| Substance Name | PROPAFENONE HYDROCHLORIDE | 
| Strength Number | 225 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Antiarrhythmic [EPC] |